Singapore

Roche Diagnostics Singapore

Present since 1998 | 39.5% market share in in-vitro diagnostics | 100% market share in HPV testing

From 2018 – 2019

More than 50% of employees are women | SGD 218,000+ spent on healthcare-related contributions | 100+ new diagnostics solutions registered

The Healthcare Landscape in Singapore

Singapore offers Universal Health Coverage (UHC) through a combination of health subsidies, multi-layered healthcare financing schemes and private individual savings – all administered at a national level. Efforts are underway to lower the burden of chronic disease through education and health promotion initiatives.

Our Contribution to Sustainability in Singapore

• Delivering patient-centric innovation:  In line with the government’s Smart Nation initiative, we partnered with an artificial intelligence start-up, ConnectedLife, to develop a pilot mobile application which measures blood-thinning treatment levels in real-time. This pilot targeted 150 patients with heart valve replacement to transmit their INR levels automatically and securely to their healthcare providers.
• Access to healthcare and diagnostics: As local barriers to healthcare can be complex, we worked closely with the government, nongovernmental organisations and hospitals to implement initiatives that enable our innovation to reach more patients in need.
  
  • The value of diagnostics: As cervical cancer is preventable with early detection and treatment, we launched the “Helping our Helpers” initiative in 2018 to offer human papillomavirus (HPV) testing to women and ensure they receive timely treatment. We partnered with The Society for Colposcopy and Cervical Pathology of Singapore, National Cancer Institute Singapore, KK Women’s and Children’s Hospital, and Humanitarian Organization for Migration Economics to offer free HPV DNA tests for 200 foreign domestic workers between the ages of 30 and 65.
  • Strengthening healthcare capacity: Advancing the healthcare capacity of Singapore is a core part of our sustainability strategy. We do so through partnerships with patients, healthcare organisations and healthcare professionals to increase their knowledge of the effectiveness and safety of our diagnostics. In 2018, we invested SGD 218,500 to support healthcare organisations in educating healthcare professionals.
• Fostering a great workplace:  At Roche Diagnostics Singapore, we currently employ close to 60 people, of which more than half are women. Between 2018 to 2019, we invested an average of SGD 6,380 per employee towards talent development.
  
• Supporting communities: Through our annual Roche’s Children Walk in 2018 and 2019, we raised SGD$171,000 in total to support children with chronic and life-threatening illnesses.
  
• Minimising our environmental footprint: Protecting our people and environment are as integral to our operations as our commitment to developing high-quality in vitro diagnostic solutions for our patients. We have an effective Safety, Security, Health and Environmental (SHE) protection management system that implements internal guidelines, directives and auditing that prevents and mitigates identified risks.